Journal
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
Volume 24, Issue 9, Pages 903-906Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/2047487317694464
Keywords
Atherosclerosis; eicosanoids; lipid mediators; resolution of inflammation
Categories
Funding
- Swedish Research Council [2014-2312]
- Swedish Heart and Lung Foundation [20150600, 20150683]
- Deutsche Forschungsgemeinschaft (DFG) [MU 3851/1-1]
Ask authors/readers for more resources
Background Different lipid mediators may have opposing effects on vascular inflammation. For example, whereas leukotriene B-4 (LTB4) transduces inflammation, resolvin D1 (RvD1), which is synthesized from the omega-3 fatty acid docosahexaenoic acid, facilitates the resolution of inflammation. The aim of this study was to determine the association of the RvD1/LTB4 ratio with subclinical atherosclerosis. Methods Saliva samples and ultrasound measurements of the intima media thickness of the carotid artery was obtained for 254 participants. The lipid mediators RvD1 and LTB4 were measured by enzyme-linked immunosorbent assay. Results Participants with a salivary RvD1/LTB4 ratio >1 had a significantly lower intima media thickness than those in whom LTB4 prevailed. The salivary RvD1/LTB4 ratio independently predicted carotid intima media thickness. Conclusions The ratio between the proresolving and proinflammatory salivary lipid mediators RvD1 and LTB4 may serve as a biomarker of non-resolving inflammation and its relation to intima media thickness in cardiovascular disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available